Clinical Trial News | BioPharma Dive
https://www.biopharmadive.com/topic/clinical-trials/
WEBApr 17, 2024 · By Jonathan Gardner • April 15, 2024. Neumora’s schizophrenia drug hit with clinical hold. Shares of the biotech dipped by double digits following disclosure the FDA had paused an early-stage study of Neumora’s muscarinic-targeting drug. By Jacob Bell • April 15, 2024. Ultragenyx says Angelman therapy is working, but safety questions remain.
DA: 34 PA: 7 MOZ Rank: 30